RICHMOND, Va. and HYDERABAD, India, Aug. 3, 2011 /PRNewswire/ -- Emerging and re-emerging infectious diseases, such as tuberculosis and malaria, have long been of national concern in India, a trend that continues today. Arguably, one of the best means of preparedness to deal with current and future disease outbreaks is the fortification of public health, research and drug manufacturing capabilities. India's awareness and growing economic status allow for such preparedness to fend off the next public health incident, part of which should be focused on increasing India's health and research infrastructure and capacity.
A major component of public health and research infrastructure necessary to evaluate and respond to these epidemic diseases is biocontainment laboratories. Various public, academic and private institutions in India operate biocontainment, or biosafety, labs, such as BSL2, BSL3 and BSL4. Further, many existing facilities in India can be upgraded quickly and cost-effectively to achieve higher biosafety standards. India boasts some of the highest-quality biomedical laboratory facilities in the world, and is known for being an international hotbed of biopharmaceutical production. With the imminent rise of infectious diseases in India and abroad, research, health and manufacturing facilities necessary to combat these plagues will reach new levels of demand.
Recently, a new partnership between Integrated Cleanroom Technologies Ltd. (ICLEAN; Hyderabad, India) and Alliance Biosciences (U.S.) has been developed to support the increasing demand for research and health biosafety laboratories. The result of this partnership is a unique blend of biosafety and engineering expertise, married with ICLEAN's capabilities of diverse laboratory design and construction. Alliance Biosciences, known internationally for their design and consultation surrounding high-containment biological research, clinical and diagnostic faci